CVS Health Corp (CVS)

Currency in USD
62.47
+0.37(+0.60%)
Closed·
After Hours
62.60+0.13(+0.21%)
·
CVS Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
High dividend Yield
Fair Value
Day's Range
61.1962.70
52 wk Range
43.5672.51
Key Statistics
Prev. Close
62.1
Open
62.32
Day's Range
61.19-62.7
52 wk Range
43.56-72.51
Volume
11.38M
Average Volume (3m)
8.72M
1-Year Change
4.06%
Book Value / Share
61.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CVS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
79.41
Upside
+27.11%
Members' Sentiments
Bearish
Bullish
ProTips
8 analysts have revised their earnings downwards for the upcoming period

CVS Health Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

CVS Health Corp Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corp SWOT Analysis


Strategic Turnaround
Explore CVS Health's efforts to recover Medicare Advantage margins and improve operational efficiency across its diverse healthcare portfolio
Market Positioning
CVS leverages its integrated model, combining insurance, pharmacy, and healthcare delivery to maintain a strong competitive edge in a rapidly evolving industry
Financial Outlook
Analysts project significant profit improvements, with average price targets ranging from $66 to $82, reflecting optimism about CVS's growth potential
Regulatory Landscape
Delve into CVS's strategy for navigating potential regulatory changes in drug pricing and PBM practices, crucial for maintaining its market leadership
Read full SWOT analysis

CVS Health Corp Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of $1.81 beat expectations by 24%, with revenue reaching $98.9 billion, up 8% year-over-year
  • Full-year EPS guidance raised to $6.30-$6.40; shares rose 5.22% to $66.15 in pre-market trading
  • New initiatives include CVS CostVantage pricing model and enhanced cancer care processes
  • CEO highlights momentum in evolving environment; CFO emphasizes differentiated consumer experience
  • Challenges include medical cost trends, competitive pressures, and potential regulatory changes in Medicare Advantage
Last Updated: 31/07/2025, 15:28
Read Full Transcript

Compare CVS to Peers and Sector

Metrics to compare
CVS
Peers
Sector
Relationship
P/E Ratio
17.5x18.8x−0.5x
PEG Ratio
−0.48−0.030.00
Price/Book
1.0x2.5x2.6x
Price / LTM Sales
0.2x0.8x3.2x
Upside (Analyst Target)
28.1%53.8%45.7%
Fair Value Upside
Unlock37.3%8.6%Unlock

Analyst Ratings

20 Buy
7 Hold
0 Sell
Ratings:
27 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 79.41
(+27.11% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.59%
Dividend Yield
4.26%
Industry Median 2.41%
Annualised payout
2.66
Paid quarterly
5-Years Growth
+5.87%
Growth Streak

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
1.81 / 1.46
Revenue / Forecast
98.90B / 94.73B
EPS Revisions
Last 90 days

CVS Income Statement

People Also Watch

51.15
DAL
-3.87%
25.91
CNC
-0.61%
356.97
CDNS
-2.08%
44.23
BMY
+2.12%
237.77
UNH
-4.72%

FAQ

What Stock Exchange Does CVS Health Corp Trade On?

CVS Health Corp is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for CVS Health Corp?

The stock symbol for CVS Health Corp is "CVS."

What Is the CVS Health Corp Market Cap?

As of today, CVS Health Corp market cap is 79.23B.

What Is CVS Health Corp's Earnings Per Share (TTM)?

The CVS Health Corp EPS (TTM) is 3.59.

When Is the Next CVS Health Corp Earnings Date?

CVS Health Corp will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is CVS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CVS Health Corp Stock Split?

CVS Health Corp has split 8 times.

How Many Employees Does CVS Health Corp Have?

CVS Health Corp has 259500 employees.

What is the current trading status of CVS Health Corp (CVS)?

As of 02 Aug 2025, CVS Health Corp (CVS) is trading at a price of 62.47, with a previous close of 62.10. The stock has fluctuated within a day range of 61.19 to 62.70, while its 52-week range spans from 43.56 to 72.51.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.